Why Did the FDA Go Easy on Generic Drug Makers After Inspections Exposed Quality & Safety Concerns?

https://youtu.be/_g0HlA5xaMo



Part 2 of our interview with investigative journalist Katherine Eban, who says generic drug manufacturers are cutting corners at the cost of safety and getting away with it. Her new book is Bottle of Lies: The Inside Story of the Generic Drug Boom. Generic drugs amount to 90% of all prescriptions filled in the U.S., most of them made in plants in India and China. Tweet